慢性乙型肝炎患者及时抗病毒治疗阻止疾病进展为肝硬化和肝衰竭  

Timely antiviral therapy to prevent patients with chronic hepatitis B from progressing to liver cirrhosis and failure

作　　者：赵芮[1] 李文松[1] 梁明[1] ZHAO Rui;LI Wen-song;LIANG Ming(Department of Infectious Disease,Second Affiliated Hospital of Harbin Medical University,Harbin 150000,China)

机构地区：[1]哈尔滨医科大学附属第二医院感染科,黑龙江哈尔滨150000

出　　处：《中国实用内科杂志》2025年第2期100-104,共5页Chinese Journal of Practical Internal Medicine

摘　　要：慢性乙型肝炎(CHB)患者及时的抗病毒治疗能够有效阻止疾病的进展,降低肝硬化和肝衰竭的发生风险,改善患者的预后。文章从病毒性肝炎发生及进展机制、临床研究探讨抗病毒治疗阻止CHB患者发展为肝硬化和肝衰竭,结合最新发布的指南和专家建议在积极抗病毒方面的指导意见,明确了及时抗病毒对于延缓肝病进展的重要作用,以期为临床实践提供有价值的参考建议。Timely administration of antiviral therapy for patients with chronic hepatitis B can effectively halt disease progression and reduce the risk of liver crrhosis and failure,hence improving the prognosis.This article discusses the antiviral therapy in preventing CHB from progressing to liver cirrhosis and failure in terms of the me chanism of viral hepatitis development and clinical research in hepatitis B,and based on the latest guidelines and expert recommendations on proactive antiviral management,it clafies the crucial role of timely antiviral therapy in delaying liver disease progression.These aim is to offer valuable reference and advice for informing clinical practice.

关 键 词：慢性乙型肝炎 抗病毒治疗 肝硬化 肝衰竭 治疗策略 

分 类 号：R512.62[医药卫生—内科学]